Canaccord starts coverage of Science Group at 'buy'.

Canaccord Genuity started coverage of Science Group on Monday with a ‘buy’ rating and 758p price target as it pointed to 14 years of strong shareholder returns.

Science Group
13 January 2025 13:43:51

Source: Sharecast

Canaccord said Science Group has an impressive and consistent track record of delivering a combination of organic and disciplined inorganic growth with minimal shareholder dilution.

"This track record, alongside management's fixation on cash generation from operations, has delivered a 12% EPS CAGR since FY10 and attractive shareholder returns, with the share price increasing more than 10x since a 40p placing in 2010 and adjusted operating profit converting into real cash flow," it said.

"We view the new debt facilities as providing existing investors with yet another opportunity for further upside and an opportunity for new investors to ride the next wave.

"Our sum-of-the-parts valuation of Science Group's operating businesses implies material upside to the current market cap.

"We contrast Science Group's 8.3x FY24E EV/EBIT multiple (CGe) with the recent PE-backed acquisitions of Alpha Financial (14.5x) and RPS Group (26.7x) in Consultancy."

N/A

ISIN: N/A

Exchange: N/A

Sell:

N/A

Buy:

N/A

Change:

Date:

Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.